Home » Topics » BioWorld

BioWorld
RSS

QUIDEL PATENT COVERS BIRTH CONTROL PRODUCTS

June 18, 1992

CEO'S SUIT DETAILS OUSTER

June 18, 1992

APPOINTMENTS AND ADVANCEMENTS

June 18, 1992

BIOTECH STOCKS FOLLOW MARKET RETREAT

June 18, 1992

HIGH SUCCESS RATE FOR IMAGING AGENT

June 17, 1992

ENVIROGEN AIMS TO TEST IPO WATERS

June 17, 1992

BAINBRIDGE SIGNS MARKETING PACT

June 17, 1992

GENE TRANSFER TECHNOLOGY PATENTED

June 17, 1992

APPOINTMENTS AND ADVANCEMENTS

June 17, 1992

SOMATIX EXPANDS GENE THERAPY PATENT POSITION

June 17, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...